Scale for the Assessment of Negative Symptoms [SANS]

Description

The Scale for the Assessment of Negative Symptoms (SANS) was developed by Nancy C. Andreasen to provide a systematic clinical assessment of the negative symptoms associated with schizophrenia. Its introduction represented an important step toward the standardized measurement of the negative syndrome in psychotic disorders.

Unlike positive symptoms such as hallucinations and delusions, negative symptoms involve the reduction or loss of normal emotional, motivational, social, and verbal functioning.

Objective

The main objective of the SANS is to assess the presence and severity of negative symptoms in individuals with schizophrenia and related psychotic disorders.

The scale can be used for clinical assessment, symptom monitoring, evaluation of treatment response, and research investigating the course and functional consequences of negative symptoms.

Main Dimensions

The SANS evaluates five major domains:

Affective Flattening or Blunting: Reduced emotional expression through facial expression, voice, gestures, and overall emotional responsiveness.

Alogia: Reduced quantity or content of speech and diminished spontaneous verbal expression.

Avolition–Apathy: Reduced motivation, initiative, and engagement in purposeful or goal-directed activities.

Anhedonia–Asociality: Reduced ability to experience pleasure and decreased interest in social interaction and interpersonal relationships.

Attention: Difficulties in concentration and maintaining attention. In contemporary conceptualizations, attentional impairment is often considered more closely related to cognitive dysfunction than to the core negative symptom domain.

Scoring

SANS items are rated on a six-point scale ranging from 0 to 5:

0 = Not present
1 = Questionable
2 = Mild
3 = Moderate
4 = Marked
5 = Severe

Higher scores indicate a greater severity of negative symptoms.

The SANS should not be interpreted as a five-item questionnaire. The five categories represent broad symptom domains, each of which includes several individual clinical ratings and an overall global rating.

Administration and Interpretation

The SANS is a clinician-rated instrument rather than a self-report questionnaire. Assessment is generally based on a clinical interview, behavioral observation, and relevant information concerning the patient’s everyday functioning.

It should be administered and interpreted by appropriately trained mental health professionals.

The results should be considered within a comprehensive psychiatric assessment and should not be used alone to establish a diagnosis of schizophrenia.

Psychometric Properties

The original work by Andreasen demonstrated the feasibility and reliability of systematically evaluating negative symptoms in schizophrenia.

Subsequent research has supported the clinical and research usefulness of the SANS and has examined its reliability, construct validity, factor structure, and relationships with other measures of schizophrenia symptom severity.

The instrument has also been compared with measures such as the Positive and Negative Syndrome Scale (PANSS) and newer negative symptom scales.

Applications

The SANS has been widely used in psychiatric and clinical research to assess the severity and progression of negative symptoms.

It may be applied to investigate associations between negative symptoms and cognitive functioning, occupational and social functioning, treatment response, quality of life, and long-term clinical outcomes.

The scale is also useful in clinical trials and longitudinal studies examining interventions designed to reduce negative symptom severity.

Conclusion

The SANS is a well-established clinical instrument for the structured assessment of negative symptoms in schizophrenia.

By evaluating affective flattening, alogia, avolition–apathy, anhedonia–asociality, and attention, the scale provides a detailed profile of negative symptom severity and remains an important tool in both psychiatric practice and schizophrenia research.

References

Andreasen, N. C. (1982). Negative symptoms in schizophrenia: Definition and reliability. Archives of General Psychiatry, 39(7), 784–788.

Andreasen, N. C. (1984). Scale for the Assessment of Negative Symptoms (SANS). University of Iowa.

Leucht, S., Barabássy, Á., Laszlovszky, I., Szatmári, B., Acsai, K., Szalai, E., et al. (2019). Linking PANSS negative symptom scores with the Clinical Global Impressions Scale: Understanding negative symptom scores in schizophrenia. Neuropsychopharmacology, 44(9), 1589–1596.

Kumari, S., Malik, M., Florival, C., Manalai, P., & Sonje, S. (2017). An assessment of five commonly used symptom rating scales in schizophrenia and comparison to newer scales. Journal of Addiction Research & Therapy, 8, 324.